About DermaSensor
DermaSensor is a company based in Miami (United States) founded in 2009 by Christopher Dewey. DermaSensor has raised $65.75 million across 7 funding rounds from investors including Ceros Capital Markets, David Matlin and Chris Dewey. DermaSensor offers products and services including DermaSensor Device. DermaSensor operates in a competitive market with competitors including MedLumics, Zerigo Health, SciBase, Hememics Biotechnologies and DAMAE Medical, among others.
- Headquarter Miami, United States
- Founders Christopher Dewey
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dermasensor, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$65.75 M (USD)
in 7 rounds
-
Latest Funding Round
$5 M (USD), Series B
Jun 10, 2026
-
Investors
Ceros Capital Markets
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DermaSensor
DermaSensor offers a comprehensive portfolio of products and services, including DermaSensor Device.
Handheld AI device for non-invasive skin cancer risk assessment.
People of DermaSensor
Unlock access to complete
Unlock access to complete
Funding Insights of DermaSensor
DermaSensor has successfully raised a total of $65.75M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in June 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in DermaSensor
DermaSensor has secured backing from 8 investors, including venture fund and angel investors. Prominent investors backing the company include Ceros Capital Markets, David Matlin and Chris Dewey.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are focused on tech startups.
|
Locked | Locked | Locked | |
|
VC and investment banking firm backed by Aegis Capital Corp
|
Locked | Locked | Locked | |
|
Early-stage technology companies are funded by Miami Angels.
|
Locked | Locked | Locked |
Investor details for DermaSensor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DermaSensor
Investment portfolio details for DermaSensor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DermaSensor
Detailed financials for DermaSensor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dermasensor Comparisons
Peer comparison for DermaSensor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DermaSensor
DermaSensor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedLumics, Zerigo Health, SciBase, Hememics Biotechnologies and DAMAE Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological tissue imaging is developed using optical coherence tomography.
|
|
| Locked | Locked | Locked |
Developer of UVB light therapy devices for monitoring Psoriasis, Vitiligo, and Eczema
|
|
| Locked | Locked | Locked |
Point-of-care device for malignant melanoma detection is provided.
|
|
| Locked | Locked | Locked |
Biopreservation platform for mammalian cells and biologics is developed.
|
|
| Locked | Locked | Locked |
Non-invasive 3D imaging devices for skin cancer diagnostics are developed.
|
Detailed competitors of DermaSensor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dermasensor
Complete news archive for DermaSensor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DermaSensor
DermaSensor was founded in 2009 and raised its 1st funding round 9 years after it was founded.
DermaSensor is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
DermaSensor is a funded company, having raised a total of $65.75M across 7 funding rounds to date.
DermaSensor was founded in 2009 and is based in Miami, United States. A handheld diagnostic device for skin cancer is developed by the company within the medical diagnostics sector. Skin lesions are evaluated using elastic scattering spectroscopy, where a light-emitting tip captures cellular irregularities below the surface. Immediate high-risk or low-risk results are provided through proprietary algorithms analyzing reflected photons.
DermaSensor's top competitors include SciBase, MedLumics and Hememics Biotechnologies.
DermaSensor offers DermaSensor Device.
DermaSensor has 8 investors. Key investors include Ceros Capital Markets, David Matlin, Chris Dewey, SternAegis Ventures, and Miami Angels.